Clinical Trial Update: 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 9-ING-41 in combination with carboplatin for salivary gland cancer, including adenoid cystic carcinoma; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Salivary Gland Cancer

Drugs mentioned

• 9-ING-41
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Glenn J. Hanna | Conditions: Salivary Gland Cancer, Recurrent Salivary Gland Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING